(305 days)
Not Found
Not Found
No
The device description and performance studies focus on the chemical composition and biocompatibility of a flushing medium, with no mention of AI/ML or data-driven analysis.
No.
The device is a flushing medium used during procedures, not a device that directly treats a medical condition or disease.
No
The device is a flushing medium used during assisted reproduction procedures. Its purpose is to facilitate the procedure, not to diagnose a condition.
No
The device description clearly states it is a "bicarbonate- and HEPES-buffered flushing medium," which is a chemical substance, not software. The performance studies also focus on biocompatibility and LAL assays, which are relevant to chemical substances, not software.
Based on the provided information, the ASP™-100 device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is "for follicle flushing during assisted reproduction procedures." This describes a procedure performed on a patient (flushing follicles), not a test performed on a sample taken from a patient to diagnose or monitor a condition.
- Device Description: The description states it's a "flushing medium." This is a substance used during a procedure, not a reagent or kit used for a diagnostic test.
- Lack of Diagnostic Elements: The description does not mention any components or processes related to analyzing a sample for diagnostic purposes (e.g., detecting analytes, measuring biomarkers, etc.).
- Regulatory Classification: The predicate device information points to the category of "Reproductive Media (21 C.F.R. § 884.61800)". This classification typically covers substances used in assisted reproduction procedures, not diagnostic tests.
IVD devices are specifically designed to perform tests on samples (like blood, urine, tissue) taken from the human body to provide information for the diagnosis, monitoring, or treatment of a disease or condition. The ASP™-100's function is to facilitate a procedural step in assisted reproduction, not to provide diagnostic information.
N/A
Intended Use / Indications for Use
ASP™-100 is intended to be used for follicle flushing during assisted reproduction procedures.
Indications For Use:
Follicle flushing.
Product codes
85 MQL
Device Description
ASP™-100 is a bicarbonate- and HEPES-buffered flushing medium for use during assisted reproduction procedures. Ready-to-use after equilibrium at +37 °C and 5% CO2.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Follicle
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Scandinavian IVF Sciences has conducted biocompatability testing on the media. This testing included cytotoxicity, rabbit vaginal irritation and delayed contact sensitization assays.
Prior to and as a condition for market release, each lot of ASP™ 100 is assayed by Limulus Amebocyte Lysate (LAL) Assay.
ASP™-100 has been used in assisted reproduction procedures for many years at many different assisted reproduction facilities. Clinical experience during that time has established its safety and effectiveness for such use.
Key Metrics
Not Found
Predicate Device(s)
Substantial equivalence established by comparison to category of Reproductive Media (21 C.F.R. § 884.61800) as provided in the FDA's Notice of Final Rule. 63 Fed. Reg. 48428, 48430 (Sept. 10, 1998)).
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 884.6180 Reproductive media and supplements.
(a)
Identification. Reproductive media and supplement are products that are used for assisted reproduction procedures. Media include liquid and powder versions of various substances that come in direct physical contact with human gametes or embryos (including water, acid solutions used to treat gametes or embryos, rinsing solutions, sperm separation media, supplements, or oil used to cover the media) for the purposes of preparation, maintenance, transfer or storage. Supplements are specific reagents added to media to enhance specific properties of the media (e.g., proteins, sera, antibiotics, etc.).(b)
Classification. Class II (special controls) (mouse embryo assay information, endotoxin testing, sterilization validation, design specifications, labeling requirements, biocompatibility testing, and clinical testing). The device, when it is phosphate-buffered saline used for washing, and short-term handling and manipulation of gametes and embryos; culture oil used as an overlay for culture media containing gametes and embryos; and water for assisted reproduction applications, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 884.9.
0
K991345
Page 1 of 2
PREMARKET NOTIFICATION SUMMARY
| Submitted by: | Scandinavian IVF Sciences AB
Mölndalsvägen 30
SE-412 63 Gothenberg
SWEDEN |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | Mr. Eiler Anderson
Vitrolife AB
Mölndalsvägen 30
SE-412 63 Gothenberg
SWEDEN
Tele: +46 31 721 80 00
Fax: +46 31 721 80 99 |
| Date Prepared: | April 16, 1999 |
| Trade Name: | ASP™-100 |
| Common Name: | Assisted Reproduction Media |
| Classification Name: | Reproductive Media and Supplements
(21 C.F.R. § 884.6180) |
| Predicate Device: | Substantial equivalence established by comparison to
category of Reproductive Media (21 C.F.R. §
884.61800) as provided in the FDA's Notice of Final
Rule. 63 Fed. Reg. 48428, 48430 (Sept. 10, 1998)). |
Description of the Device:
ASP™-100 is a bicarbonate- and HEPES-buffered flushing medium for use during assisted reproduction procedures. Ready-to-use after equilibrium at +37 °C and 5% CO2.
Intended Use:
ASP™-100 is intended to be used for follicle flushing during assisted reproduction procedures.
Technological Characteristics:
The technological characteristics of ASP™-100 are identical to other legally marketed media classified under 21 C.F.R. § 884.6180, Reproductive Media and Supplements.
1
Testing Performed:
Because ASP™-100 is intended to come into contact with gametes and the patient during assisted reproduction procedures, Scandinavian IVF Sciences has conducted biocompatability testing on the media. This testing included cytotoxicity, rabbit vaginal irritation and delayed contact sensitization assays.
Prior to and as a condition for market release, each lot of ASP™ 100 is assayed by Limulus Amebocyte Lysate (LAL) Assay. This assay is intended to assure that the media does not contain unacceptable levels of toxins. Information on the assay is provided in the labeling of the products and on a LOT-specific Certificate of Analysis provided with each delivery. The Mouse Embryo Assay is not performed on ASP™-100 because the composition of the product is neither intended for nor compatible with embryo development.
ASP™-100 has been used in assisted reproduction procedures for many years at many different assisted reproduction facilities. Clinical experience during that time has established its safety and effectiveness for such use.
2
Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized human figure with three lines representing the head, body, and legs. The figure is enclosed in a circle, with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the upper portion of the circle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
FEB 1 8 2000
Scandinavian IVF Sciences AB c/o Mr. Gary L. Yingling McKenna & Cuneo, L.L.P. 1900 K Street, N.W. Washington, D.C. 20006-1108
Re: K991345
ASPTM -100, Assisted Reproduction Media Dated: November 30, 1999 Received: November 30, 1999 Requiatory Class: II 21 CFR §884.6180/Procode: 85 MQL
Dear Mr. Yingling:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or dass III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP requlation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also. please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
CAPT Daniel G. Schultz, M.D. Acting Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
VIII. INDICATIONS FOR USE STATEMENT
510(k) Number:
Device Name:
ASP™ -100 Assisted Reproduction Media
Indications For Use:
Follicle flushing.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
| Prescription Use
| (Per 21 C.F.R. § 801.109) | ✓ |
|---|---|
| ----------------------------------------------- | ----------------------------------------- |
OR
| Over-the Counter Use | |
|---|---|
| ---------------------- | -- |
11
| (Division Sign-Off)
Division of Reproductive, Abdominal, ENT,
| and Radiological Devices | |
|---|---|
| 510(k) Number | K991345 |